Hydrogen gas inhalation inhibits progression to the "irreversible" stage of shock after severe hemorrhage in rats

Tadashi Matsuoka, Masaru Suzuki, Motoaki Sano, Kei Hayashida, Tomoyoshi Tamura, Koichiro Honma, Keiichi Fukuda, Junichi Sasaki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND Mortality of hemorrhagic shock primarily depends on whether or not the patients can endure the loss of circulating volume until radical treatment is applied. We investigated whether hydrogen (H 2) gas inhalation would influence the tolerance to hemorrhagic shock and improve survival. METHODS Hemorrhagic shock was achieved by withdrawing blood until the mean arterial blood pressure reached 30-35 mm Hg. After 60 minutes of shock, the rats were resuscitated with a volume of normal saline equal to four times the volume of shed blood. The rats were assigned to either the H 2 gas (1.3% H 2, 26% O 2, 72.7% N 2)-treated group or the control gas (26% O 2, 74% N 2)-treated group. Inhalation of the specified gas mixture began at the initiation of blood withdrawal and continued for 2 hours after fluid resuscitation. RESULTS The survival rate at 6 hours after fluid resuscitation was 80% in H 2 gas-treated rats and 30% in control gas-treated rats (p < 0.05). The volume of blood that was removed through a catheter to induce shock was significantly larger in the H 2 gas-treated rats than in the control rats. Despite losing more blood, the increase in serum potassium levels was suppressed in the H 2 gas-treated rats after 60 minutes of shock. Fluid resuscitation completely restored blood pressure in the H 2 gas-treated rats, whereas it failed to fully restore the blood pressure in the control gas-treated rats. At 2 hours after fluid resuscitation, blood pressure remained in the normal range and metabolic acidosis was well compensated in the H 2 gas-treated rats, whereas we observed decreased blood pressure and uncompensated metabolic acidosis and hyperkalemia in the surviving control gas-treated rats. CONCLUSIONS H 2 gas inhalation delays the progression to irreversible shock. Clinically, H 2 gas inhalation is expected to stabilize the subject until curative treatment can be performed, thereby increasing the probability of survival after hemorrhagic shock.

Original languageEnglish
Pages (from-to)469-475
Number of pages7
JournalJournal of Trauma and Acute Care Surgery
Volume83
Issue number3
DOIs
Publication statusPublished - 2017 Sep 1

Fingerprint

Inhalation
Hydrogen
Shock
Gases
Hemorrhage
Hemorrhagic Shock
Resuscitation
Blood Pressure
Acidosis
Blood Volume
Arterial Pressure
Hyperkalemia
Potassium
Reference Values
Catheters
Survival Rate

Keywords

  • fluid resuscitation
  • hemorrhagic shock
  • Hydrogen gas
  • inhalation therapy

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

@article{910f23d326c04e598ab167d9c86463fc,
title = "Hydrogen gas inhalation inhibits progression to the {"}irreversible{"} stage of shock after severe hemorrhage in rats",
abstract = "BACKGROUND Mortality of hemorrhagic shock primarily depends on whether or not the patients can endure the loss of circulating volume until radical treatment is applied. We investigated whether hydrogen (H 2) gas inhalation would influence the tolerance to hemorrhagic shock and improve survival. METHODS Hemorrhagic shock was achieved by withdrawing blood until the mean arterial blood pressure reached 30-35 mm Hg. After 60 minutes of shock, the rats were resuscitated with a volume of normal saline equal to four times the volume of shed blood. The rats were assigned to either the H 2 gas (1.3{\%} H 2, 26{\%} O 2, 72.7{\%} N 2)-treated group or the control gas (26{\%} O 2, 74{\%} N 2)-treated group. Inhalation of the specified gas mixture began at the initiation of blood withdrawal and continued for 2 hours after fluid resuscitation. RESULTS The survival rate at 6 hours after fluid resuscitation was 80{\%} in H 2 gas-treated rats and 30{\%} in control gas-treated rats (p < 0.05). The volume of blood that was removed through a catheter to induce shock was significantly larger in the H 2 gas-treated rats than in the control rats. Despite losing more blood, the increase in serum potassium levels was suppressed in the H 2 gas-treated rats after 60 minutes of shock. Fluid resuscitation completely restored blood pressure in the H 2 gas-treated rats, whereas it failed to fully restore the blood pressure in the control gas-treated rats. At 2 hours after fluid resuscitation, blood pressure remained in the normal range and metabolic acidosis was well compensated in the H 2 gas-treated rats, whereas we observed decreased blood pressure and uncompensated metabolic acidosis and hyperkalemia in the surviving control gas-treated rats. CONCLUSIONS H 2 gas inhalation delays the progression to irreversible shock. Clinically, H 2 gas inhalation is expected to stabilize the subject until curative treatment can be performed, thereby increasing the probability of survival after hemorrhagic shock.",
keywords = "fluid resuscitation, hemorrhagic shock, Hydrogen gas, inhalation therapy",
author = "Tadashi Matsuoka and Masaru Suzuki and Motoaki Sano and Kei Hayashida and Tomoyoshi Tamura and Koichiro Honma and Keiichi Fukuda and Junichi Sasaki",
year = "2017",
month = "9",
day = "1",
doi = "10.1097/TA.0000000000001620",
language = "English",
volume = "83",
pages = "469--475",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Hydrogen gas inhalation inhibits progression to the "irreversible" stage of shock after severe hemorrhage in rats

AU - Matsuoka, Tadashi

AU - Suzuki, Masaru

AU - Sano, Motoaki

AU - Hayashida, Kei

AU - Tamura, Tomoyoshi

AU - Honma, Koichiro

AU - Fukuda, Keiichi

AU - Sasaki, Junichi

PY - 2017/9/1

Y1 - 2017/9/1

N2 - BACKGROUND Mortality of hemorrhagic shock primarily depends on whether or not the patients can endure the loss of circulating volume until radical treatment is applied. We investigated whether hydrogen (H 2) gas inhalation would influence the tolerance to hemorrhagic shock and improve survival. METHODS Hemorrhagic shock was achieved by withdrawing blood until the mean arterial blood pressure reached 30-35 mm Hg. After 60 minutes of shock, the rats were resuscitated with a volume of normal saline equal to four times the volume of shed blood. The rats were assigned to either the H 2 gas (1.3% H 2, 26% O 2, 72.7% N 2)-treated group or the control gas (26% O 2, 74% N 2)-treated group. Inhalation of the specified gas mixture began at the initiation of blood withdrawal and continued for 2 hours after fluid resuscitation. RESULTS The survival rate at 6 hours after fluid resuscitation was 80% in H 2 gas-treated rats and 30% in control gas-treated rats (p < 0.05). The volume of blood that was removed through a catheter to induce shock was significantly larger in the H 2 gas-treated rats than in the control rats. Despite losing more blood, the increase in serum potassium levels was suppressed in the H 2 gas-treated rats after 60 minutes of shock. Fluid resuscitation completely restored blood pressure in the H 2 gas-treated rats, whereas it failed to fully restore the blood pressure in the control gas-treated rats. At 2 hours after fluid resuscitation, blood pressure remained in the normal range and metabolic acidosis was well compensated in the H 2 gas-treated rats, whereas we observed decreased blood pressure and uncompensated metabolic acidosis and hyperkalemia in the surviving control gas-treated rats. CONCLUSIONS H 2 gas inhalation delays the progression to irreversible shock. Clinically, H 2 gas inhalation is expected to stabilize the subject until curative treatment can be performed, thereby increasing the probability of survival after hemorrhagic shock.

AB - BACKGROUND Mortality of hemorrhagic shock primarily depends on whether or not the patients can endure the loss of circulating volume until radical treatment is applied. We investigated whether hydrogen (H 2) gas inhalation would influence the tolerance to hemorrhagic shock and improve survival. METHODS Hemorrhagic shock was achieved by withdrawing blood until the mean arterial blood pressure reached 30-35 mm Hg. After 60 minutes of shock, the rats were resuscitated with a volume of normal saline equal to four times the volume of shed blood. The rats were assigned to either the H 2 gas (1.3% H 2, 26% O 2, 72.7% N 2)-treated group or the control gas (26% O 2, 74% N 2)-treated group. Inhalation of the specified gas mixture began at the initiation of blood withdrawal and continued for 2 hours after fluid resuscitation. RESULTS The survival rate at 6 hours after fluid resuscitation was 80% in H 2 gas-treated rats and 30% in control gas-treated rats (p < 0.05). The volume of blood that was removed through a catheter to induce shock was significantly larger in the H 2 gas-treated rats than in the control rats. Despite losing more blood, the increase in serum potassium levels was suppressed in the H 2 gas-treated rats after 60 minutes of shock. Fluid resuscitation completely restored blood pressure in the H 2 gas-treated rats, whereas it failed to fully restore the blood pressure in the control gas-treated rats. At 2 hours after fluid resuscitation, blood pressure remained in the normal range and metabolic acidosis was well compensated in the H 2 gas-treated rats, whereas we observed decreased blood pressure and uncompensated metabolic acidosis and hyperkalemia in the surviving control gas-treated rats. CONCLUSIONS H 2 gas inhalation delays the progression to irreversible shock. Clinically, H 2 gas inhalation is expected to stabilize the subject until curative treatment can be performed, thereby increasing the probability of survival after hemorrhagic shock.

KW - fluid resuscitation

KW - hemorrhagic shock

KW - Hydrogen gas

KW - inhalation therapy

UR - http://www.scopus.com/inward/record.url?scp=85021084158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021084158&partnerID=8YFLogxK

U2 - 10.1097/TA.0000000000001620

DO - 10.1097/TA.0000000000001620

M3 - Article

VL - 83

SP - 469

EP - 475

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 3

ER -